These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 35269564)
1. COVIDomics: The Proteomic and Metabolomic Signatures of COVID-19. Costanzo M; Caterino M; Fedele R; Cevenini A; Pontillo M; Barra L; Ruoppolo M Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269564 [TBL] [Abstract][Full Text] [Related]
2. Role of Multiomics Data to Understand Host-Pathogen Interactions in COVID-19 Pathogenesis. Aggarwal S; Acharjee A; Mukherjee A; Baker MS; Srivastava S J Proteome Res; 2021 Feb; 20(2):1107-1132. PubMed ID: 33426872 [TBL] [Abstract][Full Text] [Related]
3. Proteomic Approaches to Study SARS-CoV-2 Biology and COVID-19 Pathology. Haas P; Muralidharan M; Krogan NJ; Kaake RM; Hüttenhain R J Proteome Res; 2021 Feb; 20(2):1133-1152. PubMed ID: 33464917 [TBL] [Abstract][Full Text] [Related]
4. Multiomics integration-based molecular characterizations of COVID-19. Li CX; Gao J; Zhang Z; Chen L; Li X; Zhou M; Wheelock ÅM Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34864875 [TBL] [Abstract][Full Text] [Related]
5. Molecular fingerprint by omics-based approaches in saliva from patients affected by SARS-CoV-2 infection. Pinto G; Gelzo M; Cernera G; Esposito M; Illiano A; Serpico S; Pinchera B; Gentile I; Castaldo G; Amoresano A J Mass Spectrom; 2024 Sep; 59(9):e5082. PubMed ID: 39228271 [TBL] [Abstract][Full Text] [Related]
6. Progress in understanding COVID-19: insights from the omics approach. Lin B; Liu J; Liu Y; Qin X Crit Rev Clin Lab Sci; 2021 Jun; 58(4):242-252. PubMed ID: 33375876 [TBL] [Abstract][Full Text] [Related]
7. Valuable Contributions and Lessons Learned from Proteomics and Metabolomics Studies of COVID-19. Chatterjee B; Thakur SS J Proteome Res; 2024 Oct; 23(10):4171-4187. PubMed ID: 39157976 [TBL] [Abstract][Full Text] [Related]
8. Mass spectrometry-based proteomic platforms for better understanding of SARS-CoV-2 induced pathogenesis and potential diagnostic approaches. Ahsan N; Rao RSP; Wilson RS; Punyamurtula U; Salvato F; Petersen M; Ahmed MK; Abid MR; Verburgt JC; Kihara D; Yang Z; Fornelli L; Foster SB; Ramratnam B Proteomics; 2021 May; 21(10):e2000279. PubMed ID: 33860983 [TBL] [Abstract][Full Text] [Related]
9. COVID-19 Pandemic: Hopes from Proteomics and Multiomics Research. Ray S; Srivastava S OMICS; 2020 Aug; 24(8):457-459. PubMed ID: 32427517 [TBL] [Abstract][Full Text] [Related]
10. Multiomics: unraveling the panoramic landscapes of SARS-CoV-2 infection. Wang X; Xu G; Liu X; Liu Y; Zhang S; Zhang Z Cell Mol Immunol; 2021 Oct; 18(10):2313-2324. PubMed ID: 34471261 [TBL] [Abstract][Full Text] [Related]
11. Proteomic Signature of Host Response to SARS-CoV-2 Infection in the Nasopharynx. Vanderboom PM; Mun DG; Madugundu AK; Mangalaparthi KK; Saraswat M; Garapati K; Chakraborty R; Ebihara H; Sun J; Pandey A Mol Cell Proteomics; 2021; 20():100134. PubMed ID: 34400346 [TBL] [Abstract][Full Text] [Related]
12. Human bronchial-pulmonary proteomics in coronavirus disease 2019 (COVID-19) pandemic: applications and implications. Tan HW; Xu YM; Lau ATY Expert Rev Proteomics; 2021 Nov; 18(11):925-938. PubMed ID: 34812694 [TBL] [Abstract][Full Text] [Related]
13. Proteomics-Based Insights Into the SARS-CoV-2-Mediated COVID-19 Pandemic: A Review of the First Year of Research. Praissman JL; Wells L Mol Cell Proteomics; 2021; 20():100103. PubMed ID: 34089862 [TBL] [Abstract][Full Text] [Related]
14. Proteomics in the COVID-19 Battlefield: First Semester Check-Up. Grenga L; Armengaud J Proteomics; 2021 Jan; 21(1):e2000198. PubMed ID: 33236484 [TBL] [Abstract][Full Text] [Related]
15. Deep Plasma Proteomics with Data-Independent Acquisition: Clinical Study Protocol Optimization with a COVID-19 Cohort. Ward B; Pyr Dit Ruys S; Balligand JL; Belkhir L; Cani PD; Collet JF; De Greef J; Dewulf JP; Gatto L; Haufroid V; Jodogne S; Kabamba B; Lingurski M; Yombi JC; Vertommen D; Elens L J Proteome Res; 2024 Sep; 23(9):3806-3822. PubMed ID: 39159935 [TBL] [Abstract][Full Text] [Related]
16. Proteome-wide data analysis reveals tissue-specific network associated with SARS-CoV-2 infection. Feng L; Yin YY; Liu CH; Xu KR; Li QR; Wu JR; Zeng R J Mol Cell Biol; 2020 Jun; 12(12):946-957. PubMed ID: 32642770 [TBL] [Abstract][Full Text] [Related]
17. A Multi-omics Longitudinal Study Reveals Alteration of the Leukocyte Activation Pathway in COVID-19 Patients. Suvarna K; Salkar A; Palanivel V; Bankar R; Banerjee N; Gayathri J Pai M; Srivastava A; Singh A; Khatri H; Agrawal S; Shrivastav O; Shastri J; Srivastava S J Proteome Res; 2021 Oct; 20(10):4667-4680. PubMed ID: 34379420 [TBL] [Abstract][Full Text] [Related]
18. Open Science Resources for the Mass Spectrometry-Based Analysis of SARS-CoV-2. Bittremieux W; Adams C; Laukens K; Dorrestein PC; Bandeira N J Proteome Res; 2021 Mar; 20(3):1464-1475. PubMed ID: 33605735 [TBL] [Abstract][Full Text] [Related]
19. Development of a multiomics model for identification of predictive biomarkers for COVID-19 severity: a retrospective cohort study. Byeon SK; Madugundu AK; Garapati K; Ramarajan MG; Saraswat M; Kumar-M P; Hughes T; Shah R; Patnaik MM; Chia N; Ashrafzadeh-Kian S; Yao JD; Pritt BS; Cattaneo R; Salama ME; Zenka RM; Kipp BR; Grebe SKG; Singh RJ; Sadighi Akha AA; Algeciras-Schimnich A; Dasari S; Olson JE; Walsh JR; Venkatakrishnan AJ; Jenkinson G; O'Horo JC; Badley AD; Pandey A Lancet Digit Health; 2022 Sep; 4(9):e632-e645. PubMed ID: 35835712 [TBL] [Abstract][Full Text] [Related]
20. Altered high-density lipoprotein composition and functions during severe COVID-19. Begue F; Tanaka S; Mouktadi Z; Rondeau P; Veeren B; Diotel N; Tran-Dinh A; Robert T; Vélia E; Mavingui P; Lagrange-Xélot M; Montravers P; Couret D; Meilhac O Sci Rep; 2021 Jan; 11(1):2291. PubMed ID: 33504824 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]